阿尔法陶医疗 DRTS
$13.72 +$0.42 (+3.16%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.01 +2.08%
开盘$13.51
昨收$13.30
当日区间$13.16 – $13.98
成交量418.0K
市值$1.27B
市盈率（TTM）–
股息率–
DRTS 相关新闻
匹配 Alpha Tau Medical 或代码 DRTS 的头条新闻，按最新排序。
- Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $30 正面
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $16
- Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $17
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $16 正面
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15
- Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $17 正面
- Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15
- Ladenburg Thalmann Initiates Alpha Tau Medical(DRTS.US) With Buy Rating, Announces Target Price $14
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $15 正面
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $12
- Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $9 正面
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $12 正面
- Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $30
- H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $16
暂无评论——快来第一个聊聊 DRTS。
登录后参与讨论。